HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells
- PMID: 27755964
HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells
Abstract
Objective: Reprogramming energy metabolism has been defined as the ninth hallmark of cancer; glucose deprivation might be a novel, feasible and effective approach for cancer treatment. However, the comprehensive illustration of behavior alteration of hepatocellular carcinoma (HCC) cells induced by glucose restriction is lacking and associated molecular mechanism is still unclear.
Methods: Three human HCC cell lines were cultured with normal control (25.0 mM D-glucose) and low glucose (5.5 mM D-glucose) Dulbecco's modified Eagle's medium. Cell migration ability was assessed by both transwell migration assay and wound healing assay. Levels of heat shock factor 1 (HSF1) and epithelial-mesenchymal transition (EMT) markers, E-cadherin and N-cadherin, were estimated by real-time polymerase chain reaction and western blotting. Moreover, low glucose-induced inhibition of EMT-associated migration via the HSF1 was demonstrated in HCC cells by knocking down HSF1 with the HSF1 siRNA technique; in terms of molecular mechanism, direct regulation of HSF1 on snail1 expression was identified by chromatin immunoprecipitation followed by Luciferase reporter assay.
Results: Herein, we showed that low glucose culture hampered typical EMT-like morphological change, "cadherin switching," and cell migration of HCC cells and further demonstrated that persistent down-regulation of HSF1 induced by glucose restriction, resulting in direct inhibition of snail1 expression and promoting the up-regulation of E-cadherin expression, and HSF1 was required for EMT-associated migration of HCC cells when cultured with low glucose media.
Conclusion: All these results illustrate that glucose restriction can repress the EMT and migration of HCC cells, and demonstrate the importance of HSF1 to our understanding on HCC treatment as a novel and effective therapeutic target or adjuvant strategy.
Similar articles
-
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196. World J Gastroenterol. 2015. PMID: 25574092 Free PMC article.
-
Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.Cell Physiol Biochem. 2017;41(4):1584-1595. doi: 10.1159/000470824. Epub 2017 Mar 27. Cell Physiol Biochem. 2017. PMID: 28334716
-
STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.Oncol Rep. 2015 Apr;33(4):1872-82. doi: 10.3892/or.2015.3783. Epub 2015 Feb 4. Oncol Rep. 2015. PMID: 25653024
-
Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention.J Exp Clin Cancer Res. 2014 Aug 2;33(1):62. doi: 10.1186/s13046-014-0062-0. J Exp Clin Cancer Res. 2014. PMID: 25084828 Free PMC article. Review.
-
Pleiotropic role of HSF1 in neoplastic transformation.Curr Cancer Drug Targets. 2014;14(2):144-55. doi: 10.2174/1568009614666140122155942. Curr Cancer Drug Targets. 2014. PMID: 24467529 Free PMC article. Review.
Cited by
-
HSF1Base: A Comprehensive Database of HSF1 (Heat Shock Factor 1) Target Genes.Int J Mol Sci. 2019 Nov 19;20(22):5815. doi: 10.3390/ijms20225815. Int J Mol Sci. 2019. PMID: 31752429 Free PMC article.
-
HSF1/AMPKα2 mediated alteration of metabolic phenotypes confers increased oxaliplatin resistance in HCC cells.Am J Cancer Res. 2019 Nov 1;9(11):2349-2363. eCollection 2019. Am J Cancer Res. 2019. PMID: 31815039 Free PMC article.
-
An Increase in HSF1 Expression Directs Human Mammary Epithelial Cells toward a Mesenchymal Phenotype.Cancers (Basel). 2023 Oct 12;15(20):4965. doi: 10.3390/cancers15204965. Cancers (Basel). 2023. PMID: 37894333 Free PMC article.
-
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma.Cancer Biol Ther. 2023 Dec 31;24(1):1-9. doi: 10.1080/15384047.2022.2156242. Cancer Biol Ther. 2023. PMID: 36482717 Free PMC article.
-
EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.J Cell Mol Med. 2019 Oct;23(10):6942-6954. doi: 10.1111/jcmm.14579. Epub 2019 Jul 31. J Cell Mol Med. 2019. PMID: 31368152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous